Clinical Trials Sponsored by Woolsey Pharmaceuticals
Total 19636 results
-
Alnylam PharmaceuticalsRecruitingEarly-Onset Alzheimer DiseaseUnited Kingdom, United States, Netherlands, Canada
-
EOM PharmaceuticalsRecruitingCOVID-19 Pneumonia | COVID-19 Respiratory Infection | COVID-19 Acute Respiratory Distress SyndromeBrazil
-
Regeneron PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaMexico, Korea, Republic of, Turkey, Italy, United Kingdom, Thailand, Poland, Singapore, Spain, Taiwan, Canada, Japan, United States, Malaysia, Greece, Romania, Hungary
-
Jazz PharmaceuticalsRecruitingTuberous Sclerosis Complex | Dravet Syndrome | Lennox Gastaut SyndromeUnited States
-
Eledon PharmaceuticalsRecruitingKidney TransplantCanada, Australia, United Kingdom
-
Alnylam PharmaceuticalsRecruitingPrimary Hyperoxaluria Type 1France, Spain, United States, Israel, Belgium, Switzerland, Germany, United Kingdom, Italy, Canada
-
Regeneron PharmaceuticalsRecruiting
-
Jazz PharmaceuticalsRecruiting
-
Processa PharmaceuticalsRecruitingAdvanced Cancer | Refractory Cancer | Tumor GastricUnited States
-
Ferring PharmaceuticalsRecruiting
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid TumorsUnited States, Turkey
-
Regeneron PharmaceuticalsRecruiting
-
Alnylam PharmaceuticalsRecruitingTransthyretin-Mediated Amyloidosis | ATTR AmyloidosisIsrael, Italy, Netherlands, Spain, United States, France, Denmark, Germany, Portugal, Brazil, Taiwan
-
Vanda PharmaceuticalsRecruitingGastroparesis | Diabetic Gastroparesis | Idiopathic GastroparesisUnited States
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States
-
Regeneron PharmaceuticalsRecruiting
-
Vanda PharmaceuticalsRecruitingSleep Disturbances in Smith-Magenis SyndromeUnited States
-
Cumberland PharmaceuticalsRecruitingPathologic Processes | Skin Diseases | Autoimmune Diseases | Connective Tissue Diseases | Scleroderma, Systemic | Scleroderma, Diffuse | Scleroderma, Limited | Sclerosis, Progressive SystemicUnited States, India
-
Alnylam PharmaceuticalsApproved for marketingAcute Hepatic Porphyria
-
Sparrow PharmaceuticalsActive, not recruitingAutonomous Cortisol Secretion (ACS) | ACTH-Independent Cushing Syndrome | ACTH-Independent Adrenal Cushing Syndrome, SomaticUnited States, Romania, United Kingdom
-
Dizal PharmaceuticalsActive, not recruitingNon-Small Cell Lung CancerKorea, Republic of, Spain, United States, France, Taiwan, Italy, China, Argentina, Australia, Malaysia, Canada, Japan, Chile
-
Marinus PharmaceuticalsActive, not recruitingStatus EpilepticusUnited States, Australia, Canada
-
Inovio PharmaceuticalsActive, not recruiting
-
Inovio PharmaceuticalsActive, not recruitingUrothelial CarcinomaUnited States
-
Vanda PharmaceuticalsTerminatedAtopic DermatitisUnited States
-
Alnylam PharmaceuticalsActive, not recruitingHypertensionUnited States, Canada, United Kingdom, Puerto Rico, Ukraine
-
Marinus PharmaceuticalsEnrolling by invitationTuberous Sclerosis ComplexUnited States, Spain, United Kingdom, China, Italy, France, Israel, Germany, Canada, Australia
-
Regeneron PharmaceuticalsActive, not recruiting
-
Regeneron PharmaceuticalsActive, not recruitingDiabetic Macular Edema (DME) | Neovascular Age-Related Macular Degeneration (nAMD)United States
-
BioCryst PharmaceuticalsTerminatedParoxysmal Nocturnal Hemoglobinuria | PNHUnited Kingdom, Austria, South Africa
-
Arrowhead PharmaceuticalsActive, not recruitingFamilial ChylomicronemiaKorea, Republic of, Canada, Australia, Singapore, Belgium, Spain, Japan, United States, Austria, Germany, Ireland, Oman, Poland, Israel, New Zealand, Argentina, France, Croatia, Mexico, Serbia, Turkey
-
BioCryst PharmaceuticalsTerminatedImmunoglobulin A Nephropathy | Membranous Nephropathy | Complement 3 GlomerulopathyFrance, Italy, Spain, United Kingdom
-
Regeneron PharmaceuticalsTerminated
-
Aerie PharmaceuticalsCompletedDry Eye DiseaseUnited States
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 (PH1) | Primary HyperoxaluriaUnited States, France, United Kingdom, Israel, Germany
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerUnited States, Korea, Republic of, Chile, Canada
-
Alnylam PharmaceuticalsCompletedAmyloidosis, Familial | Transthyretin AmyloidosisFrance, Germany, Italy, Portugal, Spain, Sweden, United Kingdom
-
Primus PharmaceuticalsWithdrawnDiabetic UlcersUnited States
-
Intercept PharmaceuticalsActive, not recruitingPrimary Biliary CholangitisNetherlands, United Kingdom, Korea, Republic of, Germany, Australia, Estonia, Belgium, France, Czechia, Croatia, Greece, Hungary, Israel, Lithuania, Norway, Poland, Spain
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing CancersUnited States, Canada, Korea, Republic of
-
Modra PharmaceuticalsCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States, Germany, Hungary, Poland, Russian Federation, Czechia
-
Adial PharmaceuticalsCompletedAlcohol Use DisorderBulgaria, Croatia, Estonia, Finland, Latvia, Poland, Sweden
-
Endo PharmaceuticalsTerminatedPeyronie's DiseaseUnited States
-
Regeneron PharmaceuticalsActive, not recruitingVenous ThromboembolismPoland, Latvia, Canada, Belgium, Bulgaria, Hungary, Lithuania
-
Regeneron PharmaceuticalsSuspendedNon-Small Cell Lung Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma | Basal Cell Carcinoma | Oropharynx Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Australia
-
Xeris PharmaceuticalsCompletedDiabetes Mellitus, Type 1 | Insulin-dependent Diabetes MellitusUnited States
-
Vanda PharmaceuticalsCompleted
-
Vanda PharmaceuticalsCompletedPerformance AnxietyUnited States